Two Sigma Investments LP increased its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 73.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 857,867 shares of the company's stock after purchasing an additional 363,855 shares during the quarter. Two Sigma Investments LP owned approximately 0.21% of agilon health worth $1,630,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in AGL. Barclays PLC lifted its holdings in agilon health by 21.2% in the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company's stock valued at $4,830,000 after purchasing an additional 214,830 shares in the last quarter. Empowered Funds LLC purchased a new stake in agilon health in the 4th quarter valued at about $97,000. Rhumbline Advisers raised its holdings in agilon health by 6.2% in the 4th quarter. Rhumbline Advisers now owns 419,587 shares of the company's stock valued at $797,000 after buying an additional 24,420 shares during the period. Alberta Investment Management Corp purchased a new stake in agilon health in the 4th quarter valued at about $1,564,000. Finally, Ieq Capital LLC purchased a new stake in agilon health in the 4th quarter valued at about $26,000.
agilon health Stock Down 3.5%
Shares of agilon health stock traded down $0.08 on Wednesday, reaching $2.19. 4,694,979 shares of the company were exchanged, compared to its average volume of 4,978,177. agilon health, inc. has a 1-year low of $1.50 and a 1-year high of $7.73. The company has a market cap of $906.55 million, a P/E ratio of -2.33 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock's 50 day moving average price is $3.69 and its 200-day moving average price is $3.19.
agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.50 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm's quarterly revenue was down 4.5% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.02) earnings per share. As a group, equities analysts forecast that agilon health, inc. will post -0.59 EPS for the current year.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on AGL. The Goldman Sachs Group boosted their price objective on shares of agilon health from $2.50 to $5.00 and gave the company a "neutral" rating in a report on Thursday, May 8th. Robert W. Baird cut their price target on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a research note on Friday, March 21st. JMP Securities reiterated a "market perform" rating on shares of agilon health in a research note on Monday, April 28th. Finally, Citigroup upgraded shares of agilon health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $4.79.
Check Out Our Latest Report on AGL
agilon health Profile
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.